The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

Publications

Hohenforst-Schmidt W, Riedel A, Zarogoulidis P, Franke C, Gschwendtner A, Huang H, Machairiotis N, Dramba V, Zarogoulidis K, Brachmann J

Chronic eosinophilic pneumonia due to radiographic contrast administration: an orphan disease?

Drug design, development and therapy. 2012;6:385-9

Plavsic BM, Newman AC, Reuther WL, Terry JA, Drnovsek VH

Peripheral blood eosinophilia associated with gastrointestinal administration of iodinated contrast media.

AJR. American journal of roentgenology. 2003;180(3):751-3

Bray DA, Brown CH 3rd, Herdt JR, DeVita VT

Löffler's Syndrome as a complication of bipedal lymphangiography.

JAMA. 1970;214(2):369-71